Sunitinib (SU 11248) Malat is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRbeta, respectively[1]. Sunitinib Malat, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1alpha by inhibiting autophosphorylation and consequent RNase activation[2].
Molecular Weight:
532.56
Purity:
99.61
CAS Number:
[341031-54-7]
Formula:
C26H33FN4O7
Target:
Apoptosis,Autophagy,IRE1,Mitophagy,PDGFR,VEGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
